Tag: Bioxyne
Bioxyne signs $5.6M supply agreement to enter German medical cannabis market
Bioxyne Limited), through its subsidiary Breathe Life Sciences (BLS), has entered the German medical cannabis market by securing a commercial supply agreement worth a minimum of €3.2 million (approximately AUD 5.6 million) for FY2026.
Bioxyne granted Australia’s first GMP licence for Psilocybin and MDMA manufacturing
Bioxyne Limited's subsidiary, Breathe Life Sciences (BLS), has secured the Good Manufacturing Practice (GMP) licence for the production of medical cannabis.
Featured Article
Manufacturers should do this sooner rather than later, says precision engineer
Australian precision engineering and industrial instrumentation company CENMAC implemented ERP software when it was still a one-man operation. “I couldn’t imagine us growing to this size without MRPeasy,” says Jason Ford, Founder.
